Amyloidosis of the mesentery and blood vessel
Keywords:
Amyloidosis; mesentery; blood vesselsAbstract
Introduction: Amyloidosis is a disease of unknown etiology, characterized by the deposition of amorphous substance (amyloid) in the extracellular spaces of various organs and tissues, causing functional and structural alterations depending on the location and intensity of the deposition.
Objective: To describe the clinical, laboratory, and imaging alterations in a patient with a rare diagnosis of mesenteric amyloidosis.
Clinical case: A 43-year-old white male patient with a background of good health reports that a year ago he began experiencing liquid diarrhea, 5 to 6 times per day, without phlegm or blood, accompanied by dyspepsia, asthenia, adynamia, edema in both lower limbs, and a weight loss of 30 kilograms. On physical examination, a positive finding was subcutaneous tissue infiltration in both lower limbs up to the knees, grade II, with difficult pitting edema. He was admitted for study in the gastroenterology ward; an abdominal ultrasound and abdominal computed tomography with oral and intravenous contrast were performed, showing findings compatible with mesenteric panniculitis. Nodular erythematous duodenitis was diagnosed after performing oral panendoscopy. Mesenteric biopsy revealed histological diagnosis compatible with mesenteric amyloidosis. The patient receives multidisciplinary care from Gastroenterology, Nephrology, Hematology, and Cardiology with personalized treatment and a favorable evolution.
Conclusions: Amyloidosis is an uncommon diagnosis, for which there is no universally accepted treatment protocol. It requires multidisciplinary medical care with specific and personalized treatment depending on the extent and evolutionary stage of the disease.
Downloads
References
1. Gertz MA. Diagnosing Primary Amyloidosis. Mayo Clinic Proceedings. [Internet] 2002;77(12):1278-1279. [acceso: 18/12/2025]. Disponible en: https://doi.org/10.4065/77.12.1278
2. Lain Entralgo P. Historia de la medicina moderna y contemporánea. 2da ed. Barcelona: Editorial Científico-Médica; 1963.
3. Muchtar E, Grogan M, aus dem Siepen F, Waddington Cruz M, Misumi Y, Carroll AS, et al. Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines. Amyloid. [Internet]. 2025;32(2):93-116. [acceso: 18/12/2025]. Disponible en: https://doi.org/10.1080/13506129.2025.2463678
4. Miller DV, Bhatt KN, Bocsi GT, Chang A, Gopal PP, Hernandez M, et al. Laboratory Workup of Amyloidosis. Archives of Pathology & Laboratory Medicine. [Internet] 2026;150(3):179-193. [acceso: 18/12/2025]. Disponible en: https://doi.org/10.5858/arpa.2025-0275-CP
5. Vishal Kukreti, Matthew D Seftel, Maria Adela Aguirre, Muayad Azzam, Deborah Boedicker, Naresh Bumma, et al. American Society of Hematology (ASH) 2026 Guidelines on Diagnosis of Light Chain Amyloidosis. Blood Advances. [Internet] 2026;017073. [acceso: 18/12/2025]. Disponible en: https://doi.org/10.1182/bloodadvances.2025017073
6. Tan M, Chen Y, Ooi M, de Mel S, Tan D, Soekojo C, et al. AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management. Annals of the Academy of Medicine, Singapore. [Internet]2023;52(11):601-624. [acceso: 28/01/2026]. Disponible en: https://doi.org/10.47102/annals-acadmedsg.2023101
7. Bucurica S, Nancoff AS, Moraru MV, Bucurica A, Socol C, Balaban DV, et al. Digestive Amyloidosis Trends: Clinical, Pathological, and Imaging Characteristics. Biomedicines. [Internet] 2024;12(11):2630. [acceso: 28/01/2026]. Disponible en: https://doi.org/10.3390/biomedicines12112630
8. Rieger MJ, Flammer AJ, Gerull S, Pabst T, Auner HW, Samii K, et al. Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network. Swiss Medical Weekly. [Internet] 2025;155:4219. [acceso: 28/01/2026]. Disponible en: https://doi.org/10.57187/s.4219
9. Wu YW, Wei CH, Lin YH, Huang SY, Liu YW, Tan TD, et al. Joint position statement of the diagnosis and management of light chain amyloidosis and light chain cardiac amyloidosis by the Taiwan Society of Cardiology (TSOC) and the Hematology Society of Taiwan (HST). Journal of the Formosan Medical Association.[Internet] 2025. [acceso: 28/01/2026]. Disponible en: https://doi.org/10.1016/j.jfma.2025.05.006
10. Malone MAV, Castillo DAA, Santos HT, Kaur A, Elrafei T, Steinberg L, et al. A systematic review of the literature on localized gastrointestinal tract amyloidosis: Presentation, management and outcomes. European Journal of Haematology. [Internet]2024;113(4):400-415. [acceso:28/01/2026]. Disponible en: https://doi.org/10.1111/ejh.14269
11. Rietz M, Weber T, Schaller T, Luitjens JH, Uhrmacher L, Messmann H, et al. Severe gastroparesis complicated by gastric perforation caused by light-chain amyloidosis. Zeitschriftfür Gastroenterologie. [Internet] 2025;63(4):387-392. [acceso: 28/01/2026]. Disponible en: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2442-7944
12. Arslan DF, Inal E, Isik EG, Sanli Y. Extending Amyloidosis Diagnosis: A Rare Case of Peritoneal AL Amyloidosis Revealed by 18F-FDG PET/CT and 99mTc-PYP SPECT/CT. Clinical Nuclear Medicine.[Internet]2025;50(3):e192-e194. [acceso: 28/01/2026]. Disponible en: https://journals.lww.com/nuclearmed/abstract/2025/03000/extending_amyloidosis_diagnosis__a_rare_case_of.46.aspx
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 José Fernández Sotolongo, Yosvani Josué Ortiz Montero, Miguel Bernal Duran, Licet González Fabián

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia Creative Commons Atribución– No Comercial 4.0 que permite el uso, distribución y reproducción no comerciales y sin restricciones en cualquier medio, siempre que sea debidamente citada la fuente primaria de publicación.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada.



